Should I Buy ECG? ECG 2026 Analysis

Should You Buy Everus Construction Group Inc (ECG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

97.290

1 Day change

9.36%

52 Week Range

103.080

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now: the stock is down -6.4% to $87.31 and is sitting just above key support ($86.50), creating a favorable dip-entry setup.
Trend is still broadly bullish (SMA_5 > SMA_20 > SMA_200) and analyst targets ($97–$110) imply meaningful upside from current price.
Options positioning is strongly call-skewed (very low put/call OI ratio), consistent with bullish sentiment.
Near-term trading levels: reclaiming the pivot ($91.00) improves momentum; next upside levels are $95.51 (R1) then $98.30 (R2).

Technical Analysis

Price/Trend: Despite today’s sharp pullback (-6.4%), the moving-average stack remains bullish (SMA_5 > SMA_20 > SMA_200), suggesting the larger trend is still up.
Momentum: MACD histogram is negative (-0.252) and worsening (bearish momentum in the very near term).
RSI: RSI_6 at ~35 is near the lower end of neutral and close to oversold conditions, which often supports a bounce attempt.
Levels: Pivot $91.00; immediate support S1 $86.50 (current price $87.31 is very close); deeper support S2 $83.71; resistance R1 $95.51 and R2 $98.30.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment: Open Interest Put/Call ratio at 0.16 is strongly call-skewed (bullish positioning).
Activity: Reported options volume is 0 today (signal is mainly from positioning/open interest rather than fresh flow).
Volatility: IV (30d) ~63.63 vs historical vol ~34.77 implies elevated option pricing; IV percentile ~59 suggests IV is relatively mid-to-high vs the past year, while IV rank ~12 indicates it’s not near its annual peak.
Open interest change: Today’s open interest (1268) is elevated vs 30-day average (+114% per provided metric), suggesting increased positioning.

Technical Summary

Sell

Buy

Positive Catalysts

- Strong end-market backdrop per analysts: grid modernization, electrification, energy transition, data centers, and utility capex supporting multi-year demand.
- Earnings catalyst ahead (QDEC 2025 earnings scheduled 2026-02-12 after hours per calendar), which can re-rate shares if execution remains strong.
- Pattern-based forecast from similar setups indicates a probabilistic positive drift (provided stats show positive expected moves across 1D/1W/1M horizons).

Neutral/Negative Catalysts

- Near-term momentum is bearish (MACD negative and expanding), so follow-through selling remains possible if $86.50 breaks.
- News-driven sentiment hit: Managed Asset Portfolios sold ~~120k shares (~~$10.76M), which can pressure the stock short-term.
- Event risk: Upcoming earnings can cause a sharp move either direction and may keep the stock choppy until results are out.

Financial Performance

Latest reported quarter: 2025/Q3.
Growth: Revenue $986.82M (+29.68% YoY), Net Income $56.98M (+36.42% YoY), EPS $1.11 (+35.37% YoY).
Margins: Gross margin 12.59% (+6.60% YoY), supporting the bull case that operational performance is improving alongside growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Coverage additions leaned Neutral (Cantor Fitzgerald Neutral PT $97; Guggenheim Neutral), while Stifel maintained Buy (PT trimmed slightly to $107 from $110).
Earlier momentum was strongly positive after Q3: Stifel raised PT to $110; Oppenheimer reiterated Outperform and raised PT to $105; DA Davidson raised PT to $102 (Neutral).
Wall Street pros: strong demand tailwinds (data centers, transmission, electrification), good execution and guidance momentum, potential to outperform consensus.
Wall Street cons: some want clearer/continued margin improvement before awarding a higher multiple; mixed ratings (Buy/Outperform vs multiple Neutrals) suggests “prove-it” is still part of the story.
Influential flows: Hedge funds and insiders are described as Neutral (no notable recent trend). No recent Congress trading data available.

3 Analyst Rating

Wall Street analysts forecast ECG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ECG is 100.33 USD with a low forecast of 94 USD and a high forecast of 105 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 88.960

Low

Averages

100.33

High

105

Current: 88.960

Low

Averages

100.33

High

105

Stifel

Buy

downgrade

$110 -> $107

AI Analysis

2026-01-26

Reason

Stifel

Price Target

$110 -> $107

AI Analysis

2026-01-26

downgrade

Buy

Reason

Stifel lowered the firm's price target on Everus Construction to $107 from $110 and keeps a Buy rating on the shares. The firm sees opportunity for its electrical and mechanical contractor coverage to outperform consensus expectations in Q4, noting that its survey work found that overall activity improved sequentially and was ahead of expectations, the analyst tells investors.

Cantor Fitzgerald

Neutral

initiated

$97

2026-01-23

Reason

Cantor Fitzgerald

Price Target

$97

2026-01-23

initiated

Neutral

Reason

Cantor Fitzgerald initiated coverage of Everus Construction with a Neutral rating and $97 price target. The Engineering & Construction sector is entering a multi-year investment cycle fueled by grid modernization, electrification, energy transition initiatives, and rising power demand from data centers and reshoring, while increasing utility capex is driving record backlogs, offering strong near-term revenue visibility and a durable long-term project pipeline, the analyst tells investors in a research note. Everus is a leading electrical and mechanical contractor that benefits from strong, ongoing demand in data centers, electrification, and transmission infrastructure, the firm says.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ECG

Unlock Now

ECG Should I Buy

ECG Should I Buy

Should You Buy Everus Construction Group Inc (ECG) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch